Clinical-stage biotech targeting Multiple Sclerosis & Alcohol Health. Creators of unbuzzd™️ & Lucid-MS™️. Diversified Treasury. NASDAQ: $QNTM 🧡📞1-833-304-0323
1 Adelaide Street East #801
Joined June 2018
- Tweets1.3K
- Following380
- Followers6K
- Likes701
Quantum BioPharma retweeted
$QNTM Executive Co-Chairman Anthony Durkacz joins the BioMedWire Podcast to discuss the preclinical results behind Lucid-MS. Drawing on more than 11 years of animal studies; pointing to a video on their website showing a mouse with paralyzed hind legs that can walk again after taking Lucid-MS for a number of days. ibn.fm/BTXm1
Watch the full podcast: ibn.fm/JWqdy
#QNTM #QuantumBioPharma #MultipleSclerosis
Quantum BioPharma retweeted
New @CTVW5 investigation on @BNNBloomberg from me!
Quantum BioPharma has a promising drug that could change how we treat multiple sclerosis. Then -- its stock price collapsed. The company alleges it was targeted in a case of "stock spoofing."
Quantum BioPharma retweeted
Watch Dr. Eric Hoskins, physician & former Ontario Minister of Health and Long-Term Care, who now serves as Board Director & Medical Director at Unbuzzd wellness, as he shares insights from Unbuzzd's double-blind, placebo-controlled, crossover study.
youtu.be/J-Da0nWx6iY
Quantum BioPharma retweeted
Your next investment opportunity is here. Unbuzzd is hosting an investor webinar on Thurs, Oct. 30th, 4:15 pm ET.
Regulation D offering & is for accredited investors only.
Investment opportunity: invest.unbuzzd.com/
Register for webinar: webinar.mzdigital.us/ref/44c…
Quantum BioPharma retweeted
Unbuzzd is clinically proven to accelerate alcohol metabolism and restore mental clarity. Backed by Celsius Energy beverage icon Gerry David and Shark Tank’s Kevin Harrington. Our Reg D offering is now open to accredited investors.
invest.unbuzzd.com/
Quantum BioPharma retweeted
#BurgersToBeatMS is back! 🍔 On August 21, $2 from every @awcanada Teen Burger® sold across the country will support Canadians affected by #MS.
Canada has one of the highest rates of MS in the world. Your support truly matters! Learn more: bit.ly/3ICmRR8
Quantum BioPharma retweeted
Unbuzzd Launches $5M Capital Raise to Drive Growth and Explore IPO
@QuantumBP (NASDAQ: QNTM / CSE: QNTM)
🍹 unbuzzd™ is a wellness drink that helps reduce hangover symptoms
💼 Led by former Coca-Cola and Celsius executives
🌐 Backed by top digital marketers and investment platform Dealmaker
📊 Funds will support expansion and plans for a potential public listing
Quantum BioPharma retweeted
MS Treatment Market To Reach $46.4B by 2033
Enter @QuantumBP (NASDAQ: QNTM / CSE: QNTM)
🧠 Lucid-MS is designed to protect the brain — not just shut down the immune system
🟡 Phase 1 trials confirmed it’s safe
🔵 Getting ready for next human study
🧪 Working with scientists from a Harvard-linked hospital
Real data. Real momentum. Real hope for people with Multiple Sclerosis.
Quantum BioPharma retweeted
Quantum BioPharma x Harvard-Linked Hospital: Early MS Detection in Sight
@QuantumBP (NASDAQ: QNTM / CSE: QNTM)
🧠 Partnering with Massachusetts General Hospital on PET imaging tech
➜ Pinpoints MS damage earlier — for better treatment outcomes
💡 Backs Lucid-MS — Phase 1 complete — targeting a multibillion-dollar Multiple Sclerosis market
Quantum BioPharma retweeted
#MSAwarenessMonth sure flew by quickly! Thank you to everyone who raised awareness and funds, donated to the cause, participated in our Digital Carnation Pinning on #WorldMSDay, and came together to support our incredible community throughout the month!
Quantum BioPharma retweeted
Key Milestone Hit in Multiple Sclerosis Drug Development
@QuantumBP NASDAQ:QNTM / CSE:QNTM
🧠 Lucid-MS completes 90-day safety study — no red flags reported
📄 IND application now being prepared for FDA submission
🚀 Clears major hurdle on path to Phase 2 trials
Quantum BioPharma retweeted
MS Treatment Market Could Reach $46.4 Billion by 2033
@QuantumBP NASDAQ: QNTM / CSE: QNTM is developing Lucid-MS
A new type of treatment for multiple sclerosis (MS) that aims to protect the brain, rather than just slowing the immune system.
✅ Phase 1 safety trials completed
✅ Preparing next round of human testing
✅ Developed with scientists linked to Harvard’s teaching hospital
Real science. Real progress for people living with MS.
Quantum BioPharma retweeted
MS Drug Passes Trial, $700M Lawsuit Heats Up, and Unbuzzd Expands
@QuantumBP (NASDAQ: QNTM | CSE: QNTM)
✅ Lucid-21-302, Quantum’s experimental MS drug, completes Phase 1 trial
✅ No safety concerns reported
✅ Unbuzzd now available in Puerto Rico 🇵🇷
✅ Ongoing $700M USD lawsuit alleging stock manipulation remains active
Progress across clinical, legal, and commercial fronts.
Multiple Sclerosis
Quantum BioPharma retweeted
The devastating effect of Naked Shorting/Market Manipulation on the lives of ordinary people and their families. Directly from $QNTM shareholders below. 14 Video testimonials.
@DevinNunes @DOGE_SEC @DOGE @elonmusk @SenatorTimScott @POTUS @realDonaldTrump Please tak some action!
Quantum BioPharma retweeted
$QNTM
The Anson Fund Connection.
Quantum BioPharma CEO @zsaeed says previous management accepted Toxic Funding from Anson Funds five years ago.
Question:
Did Anson Funds' Moez Kassam ever work with Virtu Financial and CIBC?
Has either name come up during Kassam's negotiations with the DOJ?
______________________
February 2025
"Virtu seems to be one of the main market makers involved in the manipulating of $QNTM stock. There seems to be a very strong connection and correlation between Virtu and CIBC.." - @zsaeed
nitter.cf/kshaughnessy2/status/1…
____________________
March 28,2025
In the company I run $QNTM almost 15 times shares traded then the free float of the company.
They do this manipulation so openly and so blatantly despite us having filed a court case against all this.
Why is there no fear of persecution for perpetrators who are doing this?
In the pics below you can see the whole float being traded in just about 7 minutes or so...
nitter.cf/zsaeed/status/19057329…
Tell me naked shorts aren't out to destroy this company
@ham59591shorts @stockmannnbroo
True that! Guess who did financing almost 5 years ago (under old management) and had 5 year warrants in $QNTM . Answer Anson funds
Quantum BioPharma retweeted
Anson Funds definitely worked/works with CIBC.
CIBC re-registered the warrant certificates that Anson funds owned in $QNTM from the toxic financing they did in $QNTM. There was such an unexplainable urgency to re-register the Anson held warrants by CIBC. The reason in our opinion could be that at that time $QNTM stock was going up in price. After the registration was complete it seemed like the stock started getting shorted heavily to bring the price back down
Quantum BioPharma retweeted
True that! Guess who did financing almost 5 years ago (under old management) and had 5 year warrants in $QNTM . Answer Anson funds
"...Moez will be going to jail .....
it's not just the banks, Moez is rolling on everyone.."
"Anson Funds and Moez Kassam in particular have had a terrible March.
The pressure from the DOJ is increasing and Moez and Anson are rolling on everyone.
What we know is the Anson Funds case is being handled by the California division of the DOJ that specialize in racketeering charges.
We also know that Moez is heading along to see this department in the DOJ on Monday, March 31 - we imagine to rat a few more people out...
... Word is spreading on the street about these developments and legitimate assets are leaving the fund like rats abandoning a burning ship..." - @stockmannnbroo
@ham59591shorts
Quantum BioPharma retweeted
$QNTM spoofing case is also in the same southern district of NY!
🚨[BONUS] PART III: Another Spoofing Case Survives a MTD🚨
The Case: Mullen Automotive, Inc. v. Clear Street Markets LLC, 1:23-cv-10637, (S.D.N.Y.)
The Docket: courtlistener.com/docket/680…
The $MULN spoofing case, in the same federal court district as $NWBO's spoofing case, just survived their own Motion to Dismiss. See Image 1.
Some highlights from the case that further support my contention that discovery is wide open for $NWBO:
"Whether these spoofing events actually had a long-term price impact is a factual question better left for later stages of litigation."
"Because there is no bright- line rule for temporal proximity in this district , and " the effects of spoofing pose questions of fact ," these allegations are sufficient at this stage to allege loss causation."
"Given the light burden for pleading loss causation , and the potential factual disputes inherent in this analysis, these arguments are better suited for summary judgment or trial."
Lastly, the Court seems to think the Defendant Market Makers "knew or recklessly ignored that they were engaging in spoofing."
"That is strong circumstantial evidence that the Defendants, who were registered broker-dealers familiar with industry rules and regulations, knew or recklessly ignored that they were engaging in spoofing."
Who are the Defendants?
IMC Financial Markets
Clear Street Markets LLC
Clear Street LLC
UBS Securities, LLC
Not quite the large defendants we see in the $NWBO case, but some big MMs nonetheless.
PART I: nitter.cf/hoffmann6383/status/19…
PART II: nitter.cf/hoffmann6383/status/19…
